4CPS-125 Use of eribulin in locally advanced or metastatic breast cancer

BACKGROUND: Eribulin has been approved for locally advanced or metastatic breast cancer after at least one previous chemotherapy regimen for advanced disease, including an anthracycline and a taxane. PURPOSE: To evaluate the effectiveness and safety of eribulin in a tertiary-level hospital. MATERIAL...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Hosp Pharm
Main Authors: Rey, MB Contreras, Martínez, MT Garrido, Madroñal, IM Carrión, Feria, D Yáñez, Gómez, E Sánchez, Martin, C Bocanegra
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 4: Clinical pharmacy services
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535592/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.216
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki